Sign in

Humaira Ilyas, MS-PhD

@humaira2204.bsky.social
44 followers 70 following 4 posts

Research Fellow in the Dept. of Biochemistry, Working with Histone Chaperones @einsteinmed. Cancer Biologist, NMR Spectroscopy, Science Communication. Book Lover, & Webseries Buff outside of lab.

PostsRepliesMedia
Reposted by Humaira Ilyas, MS-PhD
Nature Reviews Molecular Cell Biology @natrevmcb.nature.com · 11/05/2026
New Online! New developments and applications of human organoids
dlvr.it
New developments and applications of human organoids
Nature Reviews Molecular Cell Biology, Published online: 11 May 2026; doi:10.1038/s41580-026-00974-0Organoids are powerful tools for studying human development and disease mechanisms in vitro. This Review discusses their limitations and recent advances that increase their complexity to better mimic natural tissues, and the potential impact on therapeutic applications.
031
Humaira Ilyas, MS-PhD @humaira2204.bsky.social · 23/06/2025
Hi @bsky.app, I’m Humaira, a molecular biologist and protein scientist passionate about decoding complex biological systems and translating that knowledge into therapeutic insights.
320
Reposted by Humaira Ilyas, MS-PhD
David Shechter @dshechter.bsky.social · 10/04/2025
We discovered a new AML vulnerability: TTLL4 glutamylates NPM1c and helps leukemia cells thrive. Knock it down and cells differentiate and survival improves. Collab between our lab and @Gritsman_lab—funded by NIH and DoD/CDMRP. Preprint: bit.ly/42oZl09 /1
bit.ly
TTLL4 glutamyltransferase is a therapeutic target for NPM1-mutated acute myeloid leukemia
NPM1-mutated acute myeloid leukemia (AML) is defined by aberrant cytoplasmic localization of the mutant NPM1c protein, and therapeutic strategies targeting this specific disease remain limited. Here, ...
132
Reposted by Humaira Ilyas, MS-PhD
bioRxiv Cancer Bio @biorxiv-cancer.bsky.social · 10/04/2025
TTLL4 glutamyltransferase is a therapeutic target for NPM1-mutated acute myeloid leukemia www.biorxiv.org/content/10.1101/202…
032
Reposted by Humaira Ilyas, MS-PhD
bioRxivpreprint @biorxivpreprint.bsky.social · 10/04/2025
TTLL4 glutamyltransferase is a therapeutic target for NPM1-mutated acute myeloid leukemia www.biorxiv.org/content/10.1101/202…
032